Assessment of Ankaferd Blood Stopper in experimental liver ischemia reperfusion injury
Abdullah DurhanKoray KoşmazMarlen SüleymanMesut TezAbdullah SenlikciCan ErsakYılmaz ÜnalMevlut Recep PekciciFatih KaraahmetMehmet Şeneşİlknur Alkan KuşabbiEylem Pınar EserSema HücümenoğluPublished in: Turkish journal of medical sciences (2020)
ABS has a strong hepatoprotective effect due to its antioxidant and antiinflammatory effects and could therefore be used as a potential therapeutic agent for IRI.